about
Microbial induction of immunity, inflammation, and cancerA modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel diseaseInflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's diseaseEndoscopic scoring indices for evaluation of disease activity in ulcerative colitisLow dose naltrexone for induction of remission in Crohn's diseaseLow dose naltrexone for induction of remission in Crohn's diseaseLoss of intestinal core 1-derived O-glycans causes spontaneous colitis in miceThe kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel diseaseEnvironmental enteropathy: critical implications of a poorly understood condition.Light and sound - emerging imaging techniques for inflammatory bowel disease.Novel perspectives on therapeutic modulation of the gut microbiotaRectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approachExpression and Function of miR-155 in Diseases of the Gastrointestinal TractFostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join ForcesInfluence of environmental factors in the development of inflammatory bowel diseasesElderly patients and inflammatory bowel diseaseThe Role of Neuropeptides in Mouse Models of ColitisAdvanced gastrointestinal endoscopic imaging for inflammatory bowel diseasesIntestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?Pathogenic Microorganisms and Pancreatic CancerFrom the surface to the single cell: Novel endoscopic approaches in inflammatory bowel diseaseRole of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of AtherosclerosisAutoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's diseaseGenetically engineered mouse models for studying inflammatory bowel diseaseVedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn's diseaseGenetic disorders coupled to ROS deficiencyTyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancerNew insights into the dichotomous role of innate cytokines in gut homeostasis and inflammationNew insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel diseaseEnvironmental triggers for inflammatory bowel diseaseCreating diseases to understand what prevents them: genetic analysis of inflammation in the gastrointestinal tractMurine models of inflammatory bowel disease (IBD): challenges of modeling human diseaseEnvironmental risk factors for inflammatory bowel diseases: a reviewSTAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancerAdvances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiomeECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammationIntestinal epithelium in inflammatory bowel diseaseRIP2 activity in inflammatory disease and implications for novel therapeuticsMicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeuticsCentral role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gut
P2860
Q21129264-1BCF6DFC-6D23-4D63-A25C-80168F2F9DBAQ21559533-FAD3CE2B-0196-4CB6-9FCC-AC2A3B0DD281Q21560778-2591DAD5-B148-4DD7-BD27-CA06A8DFDE25Q24187044-A4040A7C-25CF-4F1D-966B-DBD83E53FB27Q24200319-0F6E8B3A-0783-4F88-9462-1B639FC5A2ABQ24201218-6984F558-DFE3-4471-A7EA-48A9E13A42C9Q24295254-8FD8CAA6-A53B-4505-A04E-EC17D1D75378Q24339515-522190A8-E8C7-4B0D-9008-88E51D953384Q24606211-C0A7CF02-110A-4EF3-B2D5-A3F9850351AEQ26739059-19513CAF-3CAC-4A1B-BF04-F55C6D037E0CQ26745706-D4D51587-4E94-4621-8BCB-CA9E4D1DCEF7Q26747744-AFAA0BA2-A346-4703-88A6-81779BAC01D3Q26749058-6763AEB3-C5A9-4C61-A345-6587CE84AA47Q26765948-43713A6B-914A-48C6-955D-0FB20FD7B0F2Q26768257-4AB73791-5352-4DAA-B159-12ADCFB6E541Q26768270-5BD63008-241A-4368-B24C-FE2CE8C5BA99Q26773507-2B2A19A7-DE5E-4BE8-A001-9D99ED2D4719Q26774485-1148D7CF-4B33-45B8-8F01-EDD091F61908Q26775240-7D0F5BE4-199F-4B33-A387-F029C05CB1FCQ26775596-98A38C24-BF81-4684-96FB-320CF7C7FEADQ26777552-F0484570-DA63-4DDD-8B21-AFFB295455CFQ26777991-5AE6AA7A-91AA-4305-BBAE-5F15A1C65C09Q26778253-0FE3C699-9FF8-4394-A73F-DD0E8F6FB4F3Q26783085-2DDFB17E-5922-4C1E-B309-1513062FADC1Q26786018-2F774092-ABFD-4C80-8F47-0C3BE4BC2201Q26799545-2EC8C4D1-A00B-425B-91FA-957202559155Q26823237-4FC6200A-9E59-4A17-B839-7EF7E1CED047Q26823773-33941D06-680C-40D0-A8B6-26B22F6346CCQ26851490-3A21A328-5058-4BDC-92E2-BF4C93142C57Q26851877-20C6B55D-2E0E-4E59-AB87-D76D5499C197Q26861393-3E83B7A6-388E-45D1-8B9A-DAD92A87668BQ26863622-2A33B2A8-79C9-4430-8102-DF8C4F81F055Q26864725-58AE6527-B65F-4825-B19A-B11C37779E8BQ26998940-F78508FC-A9DE-4FB2-94C0-DEAC1C97F808Q26999711-CC14ED63-F51D-49A5-87A3-093E32E1BC7FQ27015979-97CD1243-5033-4B27-81C7-B2C1E6AACD7EQ27022092-5D22C43F-421D-4896-81E0-3D6DC50690D2Q27025050-85C50B31-4D94-4454-84CB-806D90293BD3Q27025092-CD9FFEED-8621-4B7E-95E3-247BDF07848BQ27025911-F4932DF5-0144-4273-BFD7-89F0FA069E3F
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inflammatory bowel disease
@ast
Inflammatory bowel disease
@en
type
label
Inflammatory bowel disease
@ast
Inflammatory bowel disease
@en
prefLabel
Inflammatory bowel disease
@ast
Inflammatory bowel disease
@en
P2860
P3181
P356
P1476
Inflammatory bowel disease
@en
炎症性肠病
@zh
P2093
P2860
P304
P3181
P356
10.1056/NEJMRA0804647
P407
P5008
P577
2009-11-19T00:00:00Z